A Phase 2 Study of Fruquintinib in Combination with S-1 for Second-Line Treatment of Esophageal Squamous Cell Carcinoma after First-Line Immunotherapy Failure.
Journal of Clinical Oncology（2024）
关键词
261-374,283-424-6846-271-2644,298-145-222-7468,261-566-148,130-540-543-4790,613-135-244-3829-325,261-492-2769,2461,2461
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要